Condition
Hepcidin
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Active Not Recruiting1
Terminated1
Withdrawn1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06875947Not ApplicableActive Not Recruiting
EFFECTS of MORINGA OLEIFERA LEAF POWDERS on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA
NCT03990948TerminatedPrimary
Hepcidin Behavior in Patients With Obesity and Bariatric Surgery
NCT03073369Phase 4Withdrawn
Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease
Showing all 3 trials